CLINICAL_TRIALS
research
· 2025-07-17
Clinical Trial Update: Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT) [NA]
Summary
A clinical trial (ASCENT) evaluating adipose stem cell mitochondria supplementation to oocytes is currently recruiting for infertility-related indications.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sunkaky Medical Cooperation | Conditions: Female Infertility, Oocyte Competence | NA | Status: RECRUITING